CytoTronics, Inc.

Boston, MA · Founded 2020 · CIK 0002036555 · Medtech · Acquired

Pixel™ platform for live-cell imaging and functional analysis at scale

cytotronics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$14M
1 Form D · Oct 2024
24 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$13,500,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1263Naveris, Inc.—$34M
1264TJB Medical, Inc.—$11K
1265QCMedchain LLC——
1266CytoTronics, Inc.—$14M
1267NanoSpy, Inc.——
1268Lento Bio, Inc—$5.0M
1269MIMETAS US, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Jeffrey AbbottDirector · Executive Officer
  • Jenna AbelliDirector
  • Douglas KahnDirector
  • Sameer RohatgiDirector
  • Wenxuan WuDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.